TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $105,775,000 | +74.3% | 3,840,786 | +4.4% | 0.00% | +50.0% |
| Q1 2021 | $60,688,000 | -7.1% | 3,680,272 | +3.8% | 0.00% | 0.0% |
| Q4 2020 | $65,313,000 | +31.9% | 3,543,840 | -2.6% | 0.00% | 0.0% |
| Q3 2020 | $49,533,000 | +3.3% | 3,639,417 | +36.0% | 0.00% | 0.0% |
| Q2 2020 | $47,940,000 | +175.6% | 2,675,252 | +53.3% | 0.00% | +100.0% |
| Q1 2020 | $17,394,000 | +25.4% | 1,744,614 | +2.4% | 0.00% | – |
| Q4 2019 | $13,872,000 | -34.1% | 1,704,210 | -19.7% | 0.00% | -100.0% |
| Q3 2019 | $21,037,000 | +9.2% | 2,122,830 | +39.2% | 0.00% | 0.0% |
| Q2 2019 | $19,259,000 | +123.8% | 1,524,907 | +80.6% | 0.00% | – |
| Q1 2019 | $8,607,000 | +185.9% | 844,577 | +110.4% | 0.00% | – |
| Q4 2018 | $3,011,000 | +4.6% | 401,494 | +39.4% | 0.00% | – |
| Q3 2018 | $2,879,000 | – | 287,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,922,008 | $39,102,000 | 52.94% |
| Omega Fund Management, LLC | 2,437,603 | $24,303,000 | 10.06% |
| Baupost Group | 17,544,239 | $171,071,000 | 2.52% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $21,762,000 | 2.47% |
| RTW INVESTMENTS, LP | 3,692,424 | $36,813,000 | 1.58% |
| Camber Capital Management LP | 1,765,000 | $17,597,000 | 1.05% |
| Bain Capital Public Equity Management II, LLC | 416,670 | $4,154,000 | 0.49% |
| Rock Springs Capital Management LP | 825,000 | $8,225,000 | 0.34% |
| Birchview Capital, LP | 30,000 | $299,000 | 0.26% |
| Artal Group S.A. | 600,000 | $5,982,000 | 0.25% |